Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: A population-based cohort study

QJM: An International Journal of Medicine

Volumn 108, Issue 8, 2015, Pages 633-640

  Chen, S J ^a,b   Liao, W C ^b,c   Huang, K H ^a   Lin, C L ^b,d   Tsai, W C ^a   Kung, P T ^e   Chang, K H ^a,f   Kao, C H ^b,c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e ASIA UNIVERSITY   (Taiwan)

^f TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; GLUCOCORTICOID;

ADULT; AGE; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORTICOSTEROID THERAPY; DEPRESSION; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GENDER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLUENZA; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OSTEOPOROSIS; PATHOLOGIC FRACTURE; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; AGE DISTRIBUTION; COMPLICATION; FACTUAL DATABASE; MIDDLE AGED; OSTEOPOROTIC FRACTURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; SEX RATIO; TAIWAN; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; AGED; COHORT STUDIES; COMORBIDITY; DATABASES, FACTUAL; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PREDNISOLONE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; TAIWAN; YOUNG ADULT;

EID: 84939514891     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcv012     Document Type: Article

References (22)

1. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31:204-12.
2. Soriano JB, Visick GT, Muellerova H, Payvandi N, Hansell AL. Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. Chest 2005; 128:2099-107.
3. Adami S, Giannini S, Giorgino R, Isaia GC, Maggi S, Sinigaglia L, et al. Effect of age, weight and lifestyle factors on calcaneal quantitative ultrasound in premenopausal women:the ESOPO study. Calcif Tissue Int 2004; 74:317-21.
4. Macdonald HM, New SA, Campbell MK, Reid DM. Influence of weight and weight change on bone loss in perimenopausal and early postmenopausal Scottish women. Osteoporos Int 2005; 16:163-71.
5. Bainbridge KE, Sowers M, Lin X, Harlow SD. Risk factors for low bone mineral density and the 6-year rate of bone loss among premenopausal and perimenopausal women. Osteoporos Int 2004; 15:439-46.
6. Uusi-Rasi K, Sievänen H, Pasanen M, Oja P, Vuori I. Association of physical activity and calcium intake with the maintenance of bone mass in premenopausal women. Osteoporos Int 2002; 13:211-7.
7. Canalis E, Mazziotti G, Giustina A, Bilezikian JP. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 2007; 18:1319-28.
8. Graat-Verboom L, Wouters EF, Smeenk FW, van den Borne BE, Lunde R, Spruit MA. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J 2009; 34:209-18.
9. Vernooy JH, Kuçükaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA, et al. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 2002; 166:1218-24.
10. Ferguson GT, Calverley PM, Anderson JA, Jenkins CR, Jones PW, Willits LR, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest 2009; 136:1456-65.
11. Graat-Verboom L, Wouters EF, Smeenk FW, van den Borne BE, Lunde R, Spruit MA. Current status of research on osteoporosis in COPD: a systematic review. Eur Respir J 2009; 34:209-18.
12. El-Gazzar AG, Abdalla ME, Almahdy MA. Study of Osteoporosis in chronic obstructive pulmonary disease. Egyptian J. Chest Dis Tuber 2013; 62:91-5.
13. Kiyokawa H, Muro S, Oguma T, Sato S, Tanabe N, Takahashi T, et al. Impact of COPD exacerbations on osteoporosis assessed by chest CT scan. COPD 2012; 9:235-42.
14. Regional COPD Working Group. COPD prevalence in 12 Asia-Pacific countries and regions: projections based on the COPD prevalence estimation model. Respirology 2003; 8:192-8.
15. Canalis E, et al. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 2007; 18:1319-28.
16. Langhammer A, Forsmo S, Syversen U. Long-term therapy in COPD: any evidence of adverse effect on bone? Int J Chron Obstruct Pulmon Dis 2009; 4:365-80.
17. Mathioudakis AG, Amanetopoulou SG, Gialmanidis IP, Chatzimavridou-Grigoriadou V, Siasos G, Evangelopoulou E, et al. Impact of long-term treatment with low-dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients:aggravating or beneficial? Respirology 2013; 18:147-53.
18. Yao W, Dai W, Jiang JX, Lane NE. Glucocorticoids and osteocyte autophagy. Bone 2013; 54:279-84.
19. Ferguson GT, Calverley PM, Anderson JA, Jenkins CR, Jones PW, Willits LR, et al. Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study. Chest 2009; 136:1456-65.
20. Price D, Yawn B, Brusselle G, Rossi A. Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD. Prim Care Respir J 2013; 22:92-100.
21. Yang IA, Clarke MS, Sim EH, Fong KM. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012; 7:CD002991.
22. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease NHLBI/WHO workshop report. Rev. ed. 2011.